AzTrials
AzTrials

Small-incision Lenticule Extraction (SMILE) SurgeryNCT06806085

Analysis of Influencing Factors of High-Order Aberrations of SMILE With Lenticule Retained

An observational study of Small-incision Lenticule Extraction (SMILE) Surgery and Corneal Higher-order Wavefront Aberrations, run by Second Affiliated Hospital of Nanchang University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Analysis of Influencing Factors of High-Order Aberrations of SMILE with Lenticule Retained Read more about this study

Who is it for?
Ages 18 to 45 years
How many people
33 participants
Where
1 siteChina
Study dates
31 Oct 2024to 31 Oct 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Each subject must have complete surgical video recordings and medical records.

Who may be able to join

  • Age ≥ 18 years, gender unrestricted;
  • Equivalent spherical refraction ≤ -10.0D, corrected distance visual acuity ≥ 1.0, myopia stable for ≥ 2 years, and no contact lens wear for at least 2 weeks;
  • The patient voluntarily participates in this study, signs the informed consent form, and agrees to follow up according to the study plan;
  • Predicted postoperative residual corneal stromal thickness ≥ 280 micrometers.

Who cannot join

  • Subclinical keratoconus, keratoconus, moderate to severe corneal opacities or scars, and other ocular conditions;
  • Diabetes, keloid-prone constitution, autoimmune and connective tissue diseases, etc.;
  • Severe mental disorders such as generalized anxiety disorder, panic disorder, depression, schizophrenia, and bipolar disorder; inability to cooperate with physicians;
  • Refusal to participate in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jian Xiong, doctor contact

+8618170906556

894040417@qq.com

Fu Gui, docter contact

+861387910191

564436578@qq.com

China1 site, 1 recruiting
  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330000

    Jian J Xiong, doctor, +8618170906556, 894040417@qq.com

    Fu Gui, doctor, +8613879101919, 564436578@qq.com

    Recruiting

Other trials in China

About this study

Official title: Analysis of Influencing Factors of High-Order Aberrations of Small Incision Lenticule Extraction With Lenticule Retained

Analysis of Influencing Factors of High-Order Aberrations of SMILE with Lenticule Retained

Read the detailed description

Wavefront analysis and other objective methods are the mainstream approaches for assessing visual quality after refractive surgery, with high-order aberrations being the main observation indicators. Some studies have explored the correlation between various complications after SMILE surgery and high-order aberrations. However, research on lenticule retained after surgery has mainly focused on clinical management and case reports of overt lenticule retained, while there is a lack of high-quality observational studies on the population with covert lenticule retained (periphery residual lenticule) to serve as evidence. This often puts clinicians in a dilemma of whether to perform another surgery to remove the remnants. In summary, although research on lenticule retained after SMILE surgery is gradually increasing, systematic studies on their relationship with higher-order aberrations are still insufficient. This study aims to fill the gap in existing research by comparing and analyzing high-order aberrations between patients with and without periphery residual lenticule, providing a more comprehensive assessment of postoperative visual quality. This will offer important theoretical basis and practical guidance for improving SMILE surgical techniques and optimizing postoperative management.

Keywords
Residual Lenticule, Corneal Higher-order Wavefront Aberrations, Small-incision Lenticule Extraction
Medical subject headings
Smiling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06806085
Study groupRoleWhat they receive
lenticule retained groupNot described
Non-lenticule retained groupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Δ Higher-order Aberration

    Preoperative and postoperative Higher-order aberration difference obtained from wavefront aberrations map of corneal topography in Pentacam measurement.

    Measured: Day 90

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start31 Oct 2024
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion31 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
33 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06806085
Sponsor's protocol ID
[2024] NO.(138)
Status last verified
Oct 2025
First submitted
26 Jan 2025
Last updated
22 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Small-incision Lenticule Extraction (SMILE) Surgery and Corneal Higher-order Wavefront Aberrations, run by Second Affiliated Hospital of Nanchang University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jian Xiong, doctor (+8618170906556, 894040417@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Δ Higher-order Aberration (time frame: Day 90). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in